STAR and breast cancer: It is conceivable that, while the acetylation of StAR facilitates the accumulation of E2 for promoting breast tumorigenesis, the deacetylation of this cholesterol transporter suppresses E2 synthesis for preventing hormone-sensitive BC (Figure 4).